+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Substance Abuse Treatment Market by Substance Abuse Type, Product, Treatment Option, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5460270
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Substance Abuse Treatment Market grew from USD 7.04 billion in 2023 to USD 7.72 billion in 2024. It is expected to continue growing at a CAGR of 10.01%, reaching USD 13.74 billion by 2030.

Substance abuse treatment encompasses various methodologies aimed at helping individuals overcome addiction, dependency, and misuse of substances including drugs and alcohol. The necessity of these treatments is underscored by the increasing prevalence of substance use disorders globally, which pose significant health, social, and economic challenges. Treatments are applied across various settings, from outpatient and inpatient clinics to mental health centers, aiming to provide medical, psychological, and social support. End-use extends from rehabilitation centers to hospitals and detox centers.

Market growth is driven by rising awareness of addiction as a health condition, government initiatives for prevention and control, and advancement in healthcare infrastructure. Telemedicine has emerged as a recent potential opportunity, allowing patients remote access to therapeutic support, while medication-assisted treatment is gaining traction for its effectiveness. Innovations in personalized medicine, employing genetic and neuro-imaging studies for tailored interventions, are a significant focal area. Nonetheless, the market faces limitations such as social stigma attached to seeking treatment, high treatment costs, and regulatory hurdles. Additionally, the lack of skilled professionals and facilities in certain regions poses a challenge.

For growth, businesses should invest in digital platforms that facilitate remote monitoring and teletherapy, catering to a tech-savvy population's needs. Collaborative initiatives between public health agencies and private entities to reduce treatment costs and enhance accessibility can have a substantial impact. Addressing the challenge of social stigma is another critical factor, which can be achieved through awareness campaigns and integrating substance abuse treatment with general healthcare services to normalize its importance. Furthermore, research in developing non-addictive alternatives and exploring holistic treatments incorporating mental health therapy presents a promising avenue for innovation. The nature of the substance abuse treatment market is dynamic, shaped by technological advancements and societal changes, necessitating adaptive strategies and continuous research for sustained growth and relevance.

Understanding Market Dynamics in the Substance Abuse Treatment Market

The Substance Abuse Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing cases of tobacco addiction across the globe
    • Increasing patient awareness and higher treatment seeking rate
    • Favorable efforts from the governments to curb the use of these substances
  • Market Restraints
    • Relatively high cost of the treatment and poor treatment compliance
  • Market Opportunities
    • Emerging number of treatment centers with partnerships with private recovery facilities
    • Growing introduction of new products and therapy coupled with better reimbursement options
  • Market Challenges
    • Increasing cases of discontinuation of behavioral therapies and patients opt for outpatient care

Exploring Porter’s Five Forces for the Substance Abuse Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Substance Abuse Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Substance Abuse Treatment Market

External macro-environmental factors deeply influence the performance of the Substance Abuse Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Substance Abuse Treatment Market

The Substance Abuse Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Substance Abuse Treatment Market

The Substance Abuse Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Substance Abuse Treatment Market

The Substance Abuse Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Substance Abuse Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accord Healthcare Limited, Alkermes PLC, Amphastar Pharmaceuticals, Inc., BioCorRx, Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Elite Pharmaceuticals, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Indivior, LFB Group, Mallinckrodt LLC, Novartis International AG, Pfizer Inc., Purdue Pharma L.P., Reckitt Benckiser Group PLC, Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Substance Abuse Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Substance Abuse Type
    • Alcohol Addiction
    • Cocaine
    • Marijuana
    • Nicotine Addiction
  • Product
    • Behavioral Treatment
    • Drugs
      • Acamprosate
      • Buprenorphine
      • Bupropion
      • Disulfiram
      • Methadone
      • Naltrexone
      • Varenicline
  • Treatment Option
    • Group Counseling
    • In-patient Treatment
    • Individualized Drug Counseling
    • Long-Term Residential Treatment
    • Outpatient Treatment Programs
    • Short-Term Residential Treatment
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing cases of tobacco addiction across the globe
5.1.1.2. Increasing patient awareness and higher treatment seeking rate
5.1.1.3. Favorable efforts from the governments to curb the use of these substances
5.1.2. Restraints
5.1.2.1. Relatively high cost of the treatment and poor treatment compliance
5.1.3. Opportunities
5.1.3.1. Emerging number of treatment centers with partnerships with private recovery facilities
5.1.3.2. Growing introduction of new products and therapy coupled with better reimbursement options
5.1.4. Challenges
5.1.4.1. Increasing cases of discontinuation of behavioral therapies and patients opt for outpatient care
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Substance Abuse Treatment Market, by Substance Abuse Type
6.1. Introduction
6.2. Alcohol Addiction
6.3. Cocaine
6.4. Marijuana
6.5. Nicotine Addiction
7. Substance Abuse Treatment Market, by Product
7.1. Introduction
7.2. Behavioral Treatment
7.3. Drugs
7.3.1. Acamprosate
7.3.2. Buprenorphine
7.3.3. Bupropion
7.3.4. Disulfiram
7.3.5. Methadone
7.3.6. Naltrexone
7.3.7. Varenicline
8. Substance Abuse Treatment Market, by Treatment Option
8.1. Introduction
8.2. Group Counseling
8.3. In-patient Treatment
8.4. Individualized Drug Counseling
8.5. Long-Term Residential Treatment
8.6. Outpatient Treatment Programs
8.7. Short-Term Residential Treatment
9. Substance Abuse Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Retail Pharmacies & Drug Stores
10. Americas Substance Abuse Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Substance Abuse Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Substance Abuse Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. SUBSTANCE ABUSE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. SUBSTANCE ABUSE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. SUBSTANCE ABUSE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SUBSTANCE ABUSE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SUBSTANCE ABUSE TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COCAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BEHAVIORAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ACAMPROSATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BUPROPION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISULFIRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY METHADONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY VARENICLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP COUNSELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY IN-PATIENT TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INDIVIDUALIZED DRUG COUNSELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY LONG-TERM RESIDENTIAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT TREATMENT PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SHORT-TERM RESIDENTIAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 52. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 53. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 77. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 79. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 80. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 84. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 85. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 92. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 94. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 95. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. THAILAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 122. THAILAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. THAILAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 124. THAILAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 125. THAILAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 138. DENMARK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. DENMARK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 140. DENMARK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 141. DENMARK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. EGYPT SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. EGYPT SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 145. EGYPT SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 146. EGYPT SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. FINLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 148. FINLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. FINLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 150. FINLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 151. FINLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 155. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 156. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 161. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 168. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 170. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 171. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. NORWAY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. NORWAY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 185. NORWAY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 186. NORWAY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. POLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 188. POLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. POLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 190. POLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 191. POLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. QATAR SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 193. QATAR SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. QATAR SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 195. QATAR SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 196. QATAR SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 215. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 216. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. TURKEY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. TURKEY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. SUBSTANCE ABUSE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 243. SUBSTANCE ABUSE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Substance Abuse Treatment Market, which are profiled in this report, include:
  • AbbVie Inc.
  • Accord Healthcare Limited
  • Alkermes PLC
  • Amphastar Pharmaceuticals, Inc.
  • BioCorRx, Inc.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Elite Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Indivior
  • LFB Group
  • Mallinckrodt LLC
  • Novartis International AG
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information